GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CEL-SCI Corp (STU:LSRM) » Definitions » Shiller PE Ratio

CEL-SCI (STU:LSRM) Shiller PE Ratio : (As of May. 28, 2024)


View and export this data going back to 2007. Start your Free Trial

What is CEL-SCI Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


CEL-SCI Shiller PE Ratio Historical Data

The historical data trend for CEL-SCI's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CEL-SCI Shiller PE Ratio Chart

CEL-SCI Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CEL-SCI Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CEL-SCI's Shiller PE Ratio

For the Biotechnology subindustry, CEL-SCI's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CEL-SCI's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CEL-SCI's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CEL-SCI's Shiller PE Ratio falls into.



CEL-SCI Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

CEL-SCI's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, CEL-SCI's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.129/131.7762*131.7762
=-0.129

Current CPI (Mar. 2024) = 131.7762.

CEL-SCI Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -2.024 100.560 -2.652
201409 -2.103 100.428 -2.759
201412 -2.838 99.070 -3.775
201503 -3.927 99.621 -5.195
201506 -1.336 100.684 -1.749
201509 -2.236 100.392 -2.935
201512 0.487 99.792 0.643
201603 -1.679 100.470 -2.202
201606 -0.694 101.688 -0.899
201609 -0.143 101.861 -0.185
201612 0.303 101.863 0.392
201703 -1.075 102.862 -1.377
201706 -0.472 103.349 -0.602
201709 -0.478 104.136 -0.605
201712 -0.448 104.011 -0.568
201803 -0.251 105.290 -0.314
201806 -0.308 106.317 -0.382
201809 -0.600 106.507 -0.742
201812 0.018 105.998 0.022
201903 -0.195 107.251 -0.240
201906 -0.327 108.070 -0.399
201909 -0.118 108.329 -0.144
201912 -0.144 108.420 -0.175
202003 -0.226 108.902 -0.273
202006 -0.240 108.767 -0.291
202009 -0.110 109.815 -0.132
202012 -0.173 109.897 -0.207
202103 -0.235 111.754 -0.277
202106 -0.208 114.631 -0.239
202109 -0.162 115.734 -0.184
202112 -0.177 117.630 -0.198
202203 -0.209 121.301 -0.227
202206 -0.218 125.017 -0.230
202209 -0.212 125.227 -0.223
202212 -0.170 125.222 -0.179
202303 -0.177 127.348 -0.183
202306 -0.175 128.729 -0.179
202309 -0.150 129.860 -0.152
202312 -0.128 129.419 -0.130
202403 -0.129 131.776 -0.129

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CEL-SCI  (STU:LSRM) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


CEL-SCI Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of CEL-SCI's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CEL-SCI (STU:LSRM) Business Description

Traded in Other Exchanges
Address
8229 Boone Boulevard, Suite 802, Vienna, VA, USA, 22182
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

CEL-SCI (STU:LSRM) Headlines

No Headlines